Abstract

Epithelium-specific ETS (ESE)-1 is a prototypic member of a novel subset of the ETS transcription factor family that is predominantly expressed in cells of epithelial origin but can also be induced in other cell types including vascular endothelial and smooth muscle cells in response to inflammatory stimuli. To further define the molecular mechanisms by which the transcriptional activity of ESE-1 is regulated, we have focused our attention on identifying proteins that interact with ESE-1. We have determined that Ku70, Ku86, p300, and CREB-binding protein (CBP) are ESE-1 interacting proteins. The Ku proteins have previously been shown to bind to breaks in DNA where they function to recruit additional proteins that promote DNA repair. Interestingly, Ku70 and Ku 86 negatively regulate the transcriptional activity of ESE-1. Using a series of deletion constructs, we have determined that the Ku proteins bind to the DNA-binding domain of ESE-1. The Ku proteins inhibit the ability of ESE-1 to bind to oligonucleotide probes in gel mobility shift assays. The finding that Ku proteins can interact with other transcription factors and block their function has not been previously demonstrated. In contrast, co-transfection of p300 and CBP with ESE-1 enhances the transcriptional activity of ESE-1. Moreover, the induction of ESE-1 in response to inflammatory cytokine interleukin-1 is associated with a parallel increase of the expression of p300 in vascular endothelial cells, suggesting that in the setting of inflammation, the transcriptional activity of ESE-1 is positively modulated by interaction with the transcriptional co-activator p300. In summary, our results demonstrated that the activity of ESE-1 is positively and negatively modulated by other interacting proteins including Ku70, Ku86, p300, and CBP.

Highlights

  • Epithelium-specific ETS (ESE)-1, named ELF3, ESX, jen, and ERT, is the prototypic member of a novel subset of the ETS transcription factor family including ESE-2 and ESE-3 that under basal conditions is expressed exclusively in cells of epithelial origin [1,2,3,4,5,6]

  • These results indicate that the predominant ESE-1-binding proteins are constitutively expressed in epithelial as well as nonepithelial cells

  • The overall goal of this study was to identify additional proteins that interact with the ETS transcription factor ESE-1, because protein-protein interactions are one of the principal mechanisms by which the activity of transcription factors can be modulated

Read more

Summary

Introduction

ESE-1, named ELF3, ESX, jen, and ERT, is the prototypic member of a novel subset of the ETS transcription factor family including ESE-2 and ESE-3 that under basal conditions is expressed exclusively in cells of epithelial origin [1,2,3,4,5,6]. Expression of ESE-1 is up-regulated during the differentiation of epithelial cells. The expression of ESE-1 in keratinocytes correlates with the expression of several markers of terminal differentiation in skin, including the small proline-rich proteins SPRR2A, SPRR1, transglutaminase 3, and profillagrin. The regulatory elements of each of these genes contain conserved binding sites for ETS factors that are critical for expression of during terminal differentiation of epithelial cells (9 –12). ESE-1 binds to the ETS sites within the SPRR2A, SPRR1, SPRR3, and transglutaminase genes and positively transactivates the corresponding promoters, further supporting the notion that ESE-1 is a critical regulator of the terminal differentiation of epithelial cells [1, 5, 11, 12]. Ku 70/86 and CBP/p300 Modulation of ESE-1 Transcription muscle and endothelial cells of the aorta after the administration of endotoxin [6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call